BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 15148258)

  • 1. Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action.
    Thomas D; Hammerling BC; Wu K; Wimmer AB; Ficker EK; Kirsch GE; Kochan MC; Wible BA; Scholz EP; Zitron E; Kathöfer S; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
    Br J Pharmacol; 2004 Jun; 142(3):485-94. PubMed ID: 15148258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin.
    Thomas D; Wimmer AB; Wu K; Hammerling BC; Ficker EK; Kuryshev YA; Kiehn J; Katus HA; Schoels W; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):462-72. PubMed ID: 15098086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X).
    Thomas D; Hammerling BC; Wimmer AB; Wu K; Ficker E; Kuryshev YA; Scherer D; Kiehn J; Katus HA; Schoels W; Karle CA
    Cardiovasc Res; 2004 Dec; 64(3):467-76. PubMed ID: 15537500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone.
    Zitron E; Kiesecker C; Scholz E; Lück S; Bloehs R; Kathöfer S; Thomas D; Kiehn J; Kreye VA; Katus HA; Schoels W; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):146-56. PubMed ID: 15322737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cloned HERG potassium channels by the antiestrogen tamoxifen.
    Thomas D; Gut B; Karsai S; Wimmer AB; Wu K; Wendt-Nordahl G; Zhang W; Kathöfer S; Schoels W; Katus HA; Kiehn J; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jul; 368(1):41-8. PubMed ID: 12827215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.
    Milnes JT; Crociani O; Arcangeli A; Hancox JC; Witchel HJ
    Br J Pharmacol; 2003 Jul; 139(5):887-98. PubMed ID: 12839862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H(1) antihistamine drug promethazine directly blocks hERG K(+) channel.
    Jo SH; Hong HK; Chong SH; Lee HS; Choe H
    Pharmacol Res; 2009 Nov; 60(5):429-37. PubMed ID: 19497368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels.
    Kiesecker C; Alter M; Kathöfer S; Zitron E; Scholz EP; Thomas D; Kreuzer J; Katus HA; Bauer A; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jun; 373(3):212-20. PubMed ID: 16736158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antidepressant drug fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium channels.
    Thomas D; Gut B; Wendt-Nordahl G; Kiehn J
    J Pharmacol Exp Ther; 2002 Feb; 300(2):543-8. PubMed ID: 11805215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action.
    Kiesecker C; Zitron E; Lück S; Bloehs R; Scholz EP; Kathöfer S; Thomas D; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):423-35. PubMed ID: 15599706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clomipramine block of the hERG K+ channel: accessibility to F656 and Y652.
    Jo SH; Hong HK; Chong SH; Won KH; Jung SJ; Choe H
    Eur J Pharmacol; 2008 Sep; 592(1-3):19-25. PubMed ID: 18634780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the human ether-a-go-go-related gene potassium channel by ketanserin.
    Tu DN; Zou AR; Liao YH; Du YM; Wang XP; Li L
    Sheng Li Xue Bao; 2008 Aug; 60(4):525-34. PubMed ID: 18690396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Block of wild-type and inactivation-deficient human ether-a-go-go-related gene K+ channels by halofantrine.
    Sánchez-Chapula JA; Navarro-Polanco RA; Sanguinetti MC
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):484-91. PubMed ID: 15558243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of HERG cardiac K+ current by antifungal drug miconazole.
    Kikuchi K; Nagatomo T; Abe H; Kawakami K; Duff HJ; Makielski JC; January CT; Nakashima Y
    Br J Pharmacol; 2005 Mar; 144(6):840-8. PubMed ID: 15778703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the human ether-a-go-go-related gene potassium channel by ketamine.
    Zhang P; Xing J; Luo A; Feng J; Liu Z; Gao C; Ma J
    J Pharm Pharmacol; 2013 Sep; 65(9):1321-8. PubMed ID: 23927470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antipsychotic drug chlorpromazine inhibits HERG potassium channels.
    Thomas D; Wu K; Kathöfer S; Katus HA; Schoels W; Kiehn J; Karle CA
    Br J Pharmacol; 2003 Jun; 139(3):567-74. PubMed ID: 12788816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine.
    Scholz EP; Zitron E; Kiesecker C; Lueck S; Kathöfer S; Thomas D; Weretka S; Peth S; Kreye VA; Schoels W; Katus HA; Kiehn J; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):404-14. PubMed ID: 14557918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG.
    Rampe D; Murawsky MK; Grau J; Lewis EW
    J Pharmacol Exp Ther; 1998 Aug; 286(2):788-93. PubMed ID: 9694935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Block of hERG K+ channel and prolongation of action potential duration by fluphenazine at submicromolar concentration.
    Hong HK; Lee BH; Park MH; Lee SH; Chu D; Kim WJ; Choe H; Hee Choi B; Jo SH
    Eur J Pharmacol; 2013 Feb; 702(1-3):165-73. PubMed ID: 23395964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.